DUTANOM (Dutasteride 0.5mg)

What is DUTANOM (Dutasteride 0.5mg)?

DUTANOM (Dutasteride 0.5mg) is a generic prescription medication containing dutasteride, a 5-alpha-reductase inhibitor. It is primarily used to treat benign prostatic hyperplasia (BPH), a condition in which the prostate gland enlarges, causing urinary difficulties in men. By inhibiting the conversion of testosterone to dihydrotestosterone (DHT), DUTANOM helps reduce prostate volume, improve urinary symptoms, and lower the risk of acute urinary retention and the need for surgical intervention. It is taken orally once daily and may require several months of use before full benefits are observed.

Key features

• Active Ingredient — Dutasteride 0.5mg per capsule, a dual inhibitor of type I and type II 5-alpha-reductase enzymes.
• Prescription Required — Available only with a valid prescription due to hormonal effects and safety considerations.
• Long-Term BPH Management — Designed for chronic use to control prostate growth and related symptoms.
• DHT Suppression — Reduces serum DHT levels by over 90%, more effectively than some同类 medications.
• Once-Daily Dosing — Convenient oral capsule taken once per day, improving adherence.
• Generic Alternative — Therapeutically equivalent to brand-name formulations at potentially lower cost.
• Manufactured to International Standards — Produced under strict quality controls for consistency and safety.

Who is DUTANOM (Dutasteride 0.5mg) for?

DUTANOM is intended for adult men diagnosed with moderate to severe benign prostatic hyperplasia. It is especially beneficial for those at risk of disease progression or who have not responded adequately to alpha-blockers alone. It is not intended for use in women or children, particularly due to risks during pregnancy. Men experiencing urinary hesitancy, weak stream, or frequent nighttime urination may find symptom relief with this medication when used as directed.

How does DUTANOM (Dutasteride 0.5mg) compare?

Compared to other 5-alpha-reductase inhibitors like finasteride, DUTANOM offers broader enzyme inhibition, affecting both type I and type II isoforms, leading to more complete DHT suppression. While finasteride only inhibits type II, dutasteride’s dual action may result in greater prostate volume reduction over time. It is similar in use to other BPH medications but differs from alpha-blockers, which provide faster symptom relief but do not alter disease progression. DUTANOM is not a cure but a long-term management option that targets the hormonal root of prostate enlargement.